BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36705524)

  • 1. Lipids uniquely alter the secondary structure and toxicity of amyloid beta 1-42 aggregates.
    Zhaliazka K; Matveyenka M; Kurouski D
    FEBS J; 2023 Jun; 290(12):3203-3220. PubMed ID: 36705524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidation of molecular mechanisms by which amyloid β
    Zhaliazka K; Kurouski D
    Biochim Biophys Acta Mol Cell Biol Lipids; 2024 Aug; 1869(6):159510. PubMed ID: 38759921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidating the Role of Lipids in the Aggregation of Amyloidogenic Proteins.
    Kurouski D
    Acc Chem Res; 2023 Nov; 56(21):2898-2906. PubMed ID: 37824095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoscale Characterization of Parallel and Antiparallel β-Sheet Amyloid Beta 1-42 Aggregates.
    Zhaliazka K; Kurouski D
    ACS Chem Neurosci; 2022 Oct; 13(19):2813-2820. PubMed ID: 36122250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipids uniquely alter secondary structure and toxicity of lysozyme aggregates.
    Matveyenka M; Zhaliazka K; Rizevsky S; Kurouski D
    FASEB J; 2022 Oct; 36(10):e22543. PubMed ID: 36094052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-infrared analysis of amyloid β
    Zhaliazka K; Kurouski D
    Nanoscale; 2023 Dec; 15(48):19650-19657. PubMed ID: 38019134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific glycation of Aβ1-42 affects fibril formation and is neurotoxic.
    Ng J; Kaur H; Collier T; Chang K; Brooks AES; Allison JR; Brimble MA; Hickey A; Birch NP
    J Biol Chem; 2019 May; 294(22):8806-8818. PubMed ID: 30996005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Carotene, a Potent Amyloid Aggregation Inhibitor, Promotes Disordered Aβ Fibrillar Structure.
    Banerjee S; Baghel D; Pacheco de Oliveira A; Ghosh A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An approach for in-situ detection of gold colloid aggregates amyloid formations within the hippocampus of the Cohen's Alzheimer's disease rat model by surface enhanced raman scattering methods.
    Yokoyama K; Thomas J; Ardner W; Kieft M; Neuwirth LS; Liu W
    J Neurosci Methods; 2023 Jun; 393():109892. PubMed ID: 37230258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.
    Zhang W; Du Y; Bai M; Xi Y; Li Z; Miao J
    J Pept Sci; 2013 Mar; 19(3):159-65. PubMed ID: 23349038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two distinct β-sheet structures in Italian-mutant amyloid-beta fibrils: a potential link to different clinical phenotypes.
    Hubin E; Deroo S; Schierle GK; Kaminski C; Serpell L; Subramaniam V; van Nuland N; Broersen K; Raussens V; Sarroukh R
    Cell Mol Life Sci; 2015 Dec; 72(24):4899-913. PubMed ID: 26190022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of the carboxyl terminus of the Alzheimer Abeta peptide on its conformation, aggregation, and neurotoxic properties.
    Soreghan B; Pike C; Kayed R; Tian W; Milton S; Cotman C; Glabe CG
    Neuromolecular Med; 2002; 1(1):81-94. PubMed ID: 12025818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation of Beta-Amyloid Peptides Proximal to Zwitterionic Lipid Bilayers.
    Yang CI; Tsai BN; Huang SJ; Wang TY; Tai HC; Chan JC
    Chem Asian J; 2015 Sep; 10(9):1967-71. PubMed ID: 26097047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoscale imaging of individual amyloid aggregates extracted from brains of Alzheimer and Parkinson patients reveals presence of lipids in α-synuclein but not in amyloid β
    Zhaliazka K; Kurouski D
    Protein Sci; 2023 Apr; 32(4):e4598. PubMed ID: 36823759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct evidence for self-propagation of different amyloid-β fibril conformations.
    Spirig T; Ovchinnikova O; Vagt T; Glockshuber R
    Neurodegener Dis; 2014; 14(3):151-9. PubMed ID: 25300967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study.
    Sun Y; Qian Z; Wei G
    Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of Secondary Structure and Toxicity of α-Synuclein Oligomers and Fibrils Grown in the Presence of Phosphatidylcholine and Phosphatidylserine.
    Dou T; Matveyenka M; Kurouski D
    ACS Chem Neurosci; 2023 Sep; 14(17):3183-3191. PubMed ID: 37603792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonphosphorylated tau slows down Aβ
    Beeg M; Battocchio E; De Luigi A; Colombo L; Natale C; Cagnotto A; Corbelli A; Fiordaliso F; Diomede L; Salmona M; Gobbi M
    J Biol Chem; 2021; 296():100664. PubMed ID: 33865852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid membranes catalyse the fibril formation of the amyloid-β (1-42) peptide through lipid-fibril interactions that reinforce secondary pathways.
    Lindberg DJ; Wesén E; Björkeroth J; Rocha S; Esbjörner EK
    Biochim Biophys Acta Biomembr; 2017 Oct; 1859(10):1921-1929. PubMed ID: 28564579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.